All News

The effort to allow counselors to deny mental health services comes a week after Mississippi Governor Phil Bryant signed a law to let counselors escape similar liability and let physicians deny transgender patients access to gender reassignment care.

An updated recommendation by the US Preventive Services Task Force advises the use of low-dose aspirin in adults 50 to 69 years of age, who have an increased risk of cardiovascular disease (CVD) or colorectal cancer (CRC), are not at an increased risk of bleeding, and have a life expectancy of at least 10 years, for the prevention of CVD and CRC.

What we're reading, April 12, 2016: Zika virus scarier than initially thought; KaloBios will adopt a more transparent and "responsible" pricing model for products; and children in rural areas have more complex and expensive hospital stays.

FDA classifies this as a Class I recall, which means using the device could result in adverse health effects or death.

Concern about overnight hypoglycemic events drives decision-making for patients with type 1 diabetes.

Policy decisions can influence whether communities are supportive of or detrimental to community health and well-being. Such housing policies can also play important roles in reducing or even preventing diseases.

Nearly half of US adults said they have personally experienced unfair treatment or discrimination. These acts of discrimination were associated with higher reported stress and poorer reported health.

The approval comes following the review of a phase 2 single-arm trial in 106 patients with chronic lymphocytic leukemia who carried the 17p deletion mutation and who had received at least 1 prior therapy for their condition.

The expansion follows an early demonstration project that showed that what happens between visits is critical for patients with chronic conditions.

Sachin Jain, MD, MBA, has been named as successor to lead CareMore Health System when President Leeba Lessin retires on April 15. Dr Jain is an editorial board member of The American Journal of Managed Care and current chief medical officer of CareMore.

What we're reading, April 11, 2016: UnitedHealth calls it quits for 2 Obamacare state exchanges; study finds disparities across country in lifespans of low-income people; and Hillary Clinton and PhRMA agree on one proposal to curb drug costs.

A prospective longitudinal study that followed terminally ill cancer patients till their death has found that patients of African American origins had a poorer understanding of their survival than the white patients in the study group.

A majority of parents who seek online ratings to help decide their next visit to the doctor do not rely on online ratings-some even think that the ratings are fake.

Penn's innovative Community Health Worker model shows positive results in the outpatient settings for low-income individuals with chronic diseases.

States can greatly improve access to behavioral health services for residents by expanding Medicaid through the Affordable Care Act, HHS reported.

The intravenous acetaminophen Ofirmev has been shown to decrease hospital length of stay, opioid-related complications, and overall costs compared with traditional opioid analgesics.

A new study in behavioral cardiology establishes a strong link between posttraumatic stress disorder and an increased risk for cardiovascular diseases and deaths.

This week in managed care, the top stories included new data on statin prescriptions, a trial found the PCSK9 inhibitor Repatha successfully lowered cholesterol, but an editorial said the price might be too high to be worth it, and Farzad Mostashari, MD, discussed care transformation.

A preliminary briefing document expresses concerns over clinical benefit over existing treatments, safety, and overall risk-benefit of the drug for the subset of lung cancer patients for whom the drug has been developed.

The National Comprehensive Cancer Network (NCCN)'s annual conference has traditionally been a platform for NCCN’s Guideline updates. This year's meeting saw much more, with discussions on palliative care, biosimilars, and value in cancer care.

What we're reading, April 8, 2016: Disney demanded a soda study be withdrawn; WHO wants a reduction in the price of insulin; and hospitals need better tools to flag harmful prescription drugs.

The lawsuit, brought in 2005, took a turn in 2014 when a federal judge ordered the state to reach an agreement with the plaintiffs after finding the Florida failed to provide adequate healthcare to poor children.

Drug developer Amgen is questioning the assessment of its multiple myeloma treatments at the hands of the Institute for Clinical and Economic Review.

Patients with grade 2 glial brain tumors (gliomas) who were treated with radiation therapy (RT) and chemotherapy had a longer progression-free survival and overall survival than those who received RT alone.

The World Health Day theme highlighted the need to prevent the disease in the developing world, and the fact that many groups play a part

Intracoronary gene transfer among heart failure patients increased left ventricular function beyond standard heart failure therapy.

What we're reading, April 7, 2016: hospitals will help Louisiana pay for Medicaid expansion; Pfizer considers splitting the company after deal with Allergan falls through; and Pfizer gets 300 lawsuits dismissed.

Systems failures frustrate women who seek access to evidence-based, cost-effective contraceptive care.

The warnings on labels will come after FDA reviewed long-term safety data.

While this study focused on calculating the global burden of diabetes, it comes as advocacy groups are stepping up calls for soda taxes marketing limits to rein in the effect of unhealthy food and drink on poor countries.